First case of hemicrania continua responsive to galcanezumab

Neurol Sci. 2021 Nov;42(11):4775-4776. doi: 10.1007/s10072-021-05476-9. Epub 2021 Jul 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Headache / drug therapy
  • Humans
  • Indomethacin* / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • galcanezumab
  • Indomethacin